SLG
DVAX

Stanley-Laman Group’s Dynavax Technologies DVAX Stock Holding History

Stanley-Laman Group’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-1,500
Closed -$24K – 289
2014
Q2 		$24K Buy
+1,500
New +$22.6K ﹤0.01% 289

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Stanley-Laman Group's DVAX Position: Q3 2014 in Review

Stanley-Laman Group sold out of Dynavax Technologies (DVAX) in Q3 2014, closing a stake of 1,500 shares — an estimated $24K sold.

Stanley-Laman Group first reported a position in DVAX in Q2 2014 and held it in 1 quarter. The position peaked at $24K in Q2 2014. 110 funds tracked by Wall St. Rank hold DVAX as of Q3 2014.

  • Stanley-Laman Group reported no remaining Dynavax Technologies position as of Q3 2014 after selling out during the quarter.
  • Stanley-Laman Group sold 1,500 Dynavax Technologies shares in Q3 2014, an estimated $24K.
  • Stanley-Laman Group first reported a position in Dynavax Technologies in Q2 2014 and held it in 1 quarter.
  • Stanley-Laman Group's Dynavax Technologies position peaked at $24K in Q2 2014.
  • 110 funds tracked by Wall St. Rank held Dynavax Technologies as of Q3 2014.

Based on Stanley-Laman Group's 13F filing for Q3 2014, filed 14 Nov 2014.